IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CATALANO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.611
NA - Nord America 5.504
AS - Asia 5.227
SA - Sud America 458
AF - Africa 76
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 9
Totale 16.909
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.372
GB - Regno Unito 1.824
CN - Cina 1.774
SG - Singapore 1.750
IT - Italia 844
SE - Svezia 745
RU - Federazione Russa 534
HK - Hong Kong 459
DE - Germania 352
BR - Brasile 330
VN - Vietnam 317
NL - Olanda 276
IN - India 266
IE - Irlanda 231
TR - Turchia 222
FR - Francia 215
UA - Ucraina 167
KR - Corea 131
FI - Finlandia 100
EU - Europa 88
CA - Canada 86
ID - Indonesia 70
DK - Danimarca 58
JP - Giappone 56
CO - Colombia 47
BE - Belgio 43
AR - Argentina 39
PL - Polonia 36
BD - Bangladesh 34
AT - Austria 32
IQ - Iraq 26
CH - Svizzera 25
ES - Italia 25
MX - Messico 25
CI - Costa d'Avorio 20
GR - Grecia 20
AU - Australia 16
RO - Romania 15
MY - Malesia 13
SA - Arabia Saudita 13
ZA - Sudafrica 13
HU - Ungheria 12
CZ - Repubblica Ceca 11
IR - Iran 11
TW - Taiwan 11
UZ - Uzbekistan 11
VE - Venezuela 11
MA - Marocco 9
JM - Giamaica 8
NZ - Nuova Zelanda 8
BO - Bolivia 7
CL - Cile 7
EC - Ecuador 7
PT - Portogallo 7
PY - Paraguay 7
SC - Seychelles 7
SK - Slovacchia (Repubblica Slovacca) 7
NO - Norvegia 6
TN - Tunisia 6
AZ - Azerbaigian 5
KZ - Kazakistan 5
LB - Libano 5
MK - Macedonia 5
PK - Pakistan 5
SI - Slovenia 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
KE - Kenya 4
PA - Panama 4
BY - Bielorussia 3
DZ - Algeria 3
EG - Egitto 3
GE - Georgia 3
HR - Croazia 3
IL - Israele 3
MM - Myanmar 3
XK - ???statistics.table.value.countryCode.XK??? 3
A1 - Anonimo 2
AM - Armenia 2
BF - Burkina Faso 2
ET - Etiopia 2
GT - Guatemala 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LT - Lituania 2
LU - Lussemburgo 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
RS - Serbia 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 16.975
Salva come PNG Salva come JPEG
Città #
Southend 1.637
Singapore 891
Chandler 635
Ashburn 451
Hong Kong 404
Beijing 392
Milan 335
Santa Clara 334
Princeton 330
Seattle 234
Dublin 230
Ann Arbor 214
Council Bluffs 204
Wilmington 202
Fairfield 170
Los Angeles 161
Jacksonville 157
Dallas 133
Nanjing 129
Des Moines 110
Bengaluru 104
Woodbridge 103
San Jose 89
Buffalo 84
Redmond 84
Dong Ket 82
Guangzhou 77
Somerville 76
Serra 74
Houston 71
Cambridge 61
Berlin 60
Boardman 60
Moscow 57
Shenyang 57
Andover 55
Mountain View 55
Dearborn 54
Istanbul 54
Redwood City 54
Cangzhou 51
Jinan 51
Toronto 50
Nanchang 47
Central District 46
Sakarya 45
Bogotá 44
Brussels 41
Jakarta 41
New York 40
Shanghai 40
Hebei 39
São Paulo 39
The Dalles 39
Changsha 37
Columbus 37
Hangzhou 33
Ho Chi Minh City 33
Fuzhou 31
Tokyo 29
Hefei 26
Helsinki 26
Tianjin 26
Phoenix 25
Warsaw 23
San Diego 22
Munich 21
Zhengzhou 21
Abidjan 20
Enschede 20
Grafing 20
Jiaxing 20
Medford 20
Chicago 19
Hanoi 19
Shenzhen 19
Kunming 16
Quanzhou 16
Wuhan 16
Boston 15
Frankfurt am Main 15
Dhaka 14
Hanover 14
Taizhou 14
Seoul 13
Verona 13
Falls Church 12
London 11
Nuremberg 11
Pisa 11
Redondo Beach 11
Roxbury 11
Xiamen 11
Amsterdam 10
Bitonto 10
Haikou 10
Margão 10
Wandsworth 10
Athens 9
Belo Horizonte 9
Totale 10.216
Salva come PNG Salva come JPEG
Nome #
Arterial stiffness and 5-year mortality in patients with peripheral arterial disease 373
Radial artery compliance in patients with peripheral vascular disease 255
Finally, the big picture of morbidity and mortality in peripheral arterial disease? 248
Both HIV-infection and long-term antiretroviral therapy are associated with increased common carotid intima-media thickness in HIV-infected adolescents and young adults 244
La mutazione C677T del gene methylene tetrahydrofolate reductase nell'arteriopatia periferica 243
Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo : Evidence derived from the study of peripheral arterial disease 243
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee 240
Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT Group 219
Arterial stiffness and subendocardial viability ratio in patients with peripheral arterial disease 218
VAS european book on angiology/vascular medicine 215
The PLAT Study : a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients 213
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study 207
Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness 194
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group 193
The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease 191
The PLAT Study : hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group Progetto Lombardo Atero-Trombosi (PLAT) Study Group 187
Effect on walking distance and atherosclerosis progression of a nitric oxide-donating agent in intermittent claudication 185
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients 182
Alterazioni strutturali dell'arteria radiale in pazienti con arteriopatia aterosclerotica periferica 182
Elastic properties and structure of the radial artery in patients with type 2 diabetes 181
Thrombin generation profile in patients with steady state peripheral arterial disease 181
Impact of mild hypertriglyceridemia on fibrinolysis, Lp(a) and platelet activation index in mildly hypercolesterolemic patients 180
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group 180
Basal nitric oxide production is not reduced in patients with noninsulin-dependent diabetes mellitus 178
Lp(a) in hypertensive patients 178
Effects of treatment with verapamil SR and captopril on the lipid profile of hypertensive patients 178
Aortic augmentation index in patients with peripheral arterial disease 174
The LPA gene C93T polymorphism influences plasma lipoprotein(a) levels and is independently associated with susceptibility to peripheral arterial disease 173
Arterial damage, triglycerides, apolipoprotein and Lp(a) values in PVD patients 170
Arterial stiffness: a review in Type 2 diabetes 169
Increased superoxide anion production in humans: a possible mechanism for the pathogenesis of hypertension 165
La flunarizina nel trattamento delle arteriopatie degli arti inferiori 162
Proposed training requirements for Medical Angiology fellows. European Working Group on Medical Angiology 161
Relationship of arterial stiffness and ankle-brachial index 160
Cadralazine in combination with three different doses of atenololol in essential hypertension 155
Serum lipids and apolipoproteins in patients with essential hypertension 154
Carotid artery plaque composition : Relationship to clinical presentation and ultrasound B-mode imaging 153
Lipid profile during antihypertensive treatment. The SLIP Study Group. Study on Lipids with Isoptin Press 152
Increased aortic stiffness and related factors in patients with peripheral arterial disease 148
Arterial stiffness and its relationship to mortality in patients with peripheral artery disease 148
Energetics of walking in patients with peripheral arterial disease : a proposed functional evaluation protocol 146
A multicenter study of doxazosin in the treatment of patients with mild or moderate essential hypertension and concomitant intermittent claudication 146
Influence of storage time on whole blood platelet aggregation 145
Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia [The Oral Iloprost in severe Leg Ischaemia Study Group] 145
Long-term HIV Infection is Associated with Increased Carotid Intima Media Thickness in HIV-infected Adolescents 145
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine 145
The size of juxtaluminal hypoechoic area in ultrasound images of asymptomatic carotid plaques predicts the occurrence of stroke 144
Isradipine in the treatment of peripheral occlusive vascular disease of the lower limbs: a pilot study 141
Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease : randomized, double-blind trial 139
The case for the speciality of medical angiology 134
Endoteline e patologie umane 134
Simvastatin and the apolipoprotein profile in primary hypercholesterolemia 130
Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification 129
Skin blood flow during vasoconstrictive and vasodilative stimuli in essential hypertension patients: a laser Doppler flowmetry study 128
Epidemiology of critical limb ischaemia : north Italian data 128
Cadralazine (ISF 2469): dose-related antihypertensive activity after single oral administration to patients 128
Controlled clinical trial of cadralazine as a second-step drug in the treatment of hypertension 125
Platelet activation markers in patients with peripheral arterial disease - a prospective comparison of different platelet function tests 124
Epidemiology of peripheral artery disease in Europe : VAS educational paper 122
Fibrinolytic variables in atherosclerotic patients-comparison between patients with and without peripheral arterial-disease (PAD) 122
"No more amputations" : a complex scientific problem and a challenge for effective preventive strategy implementation on vascular field 120
The case for the specialty of medical angiology 118
Evaluation of a conservative treatment with iIoprost in severe peripheral occlusive arterial disease (POAD) : GISAP study 118
PAD awareness : role of educational project 117
Medical angiologists. Europe already has them 114
A stable strategy for European education in angiology/vascular medicine 114
Nitric oxide is involved in the insulin release in rat by L-aeginine 113
Reprinted Article "carotid artery plaque composition - Relationship to clinical presentation and ultrasound b-mode imaging" 112
Creazione e sviluppo delle UO di Angiologia 110
Arterial Stiffness 110
29th Annual Scientific Sessions, SVM Fellows Course, and International Collaboration with VAS 110
The Italian node of the research infrastructure BBMRI 107
Aging and Vascular Disease: A Multidisciplinary Overview 106
Treatment of claudication with dipyridamole and aspirin 106
Un estratto di corteccia surrenale nella terapia di supporto dei pazienti neoplastici 106
Introduction by the VAS Board 106
Fibrinolytic variables in prediction of atherothrombotic sequelae in patients with preexisting vascular ischaemic disease : the plat study 106
Il complesso antitrombofilico di parete arteriosa nella terapia delle arteriopatie obliteranti degli arti inferiori 105
A stable strategy for European education in angiology/vascular medicine 104
Arterial stiffness in young patients with peripheral arterial disease 103
Beta-TG and plasma catecholamines levels after sympathetic stimuli in hypertensives and patients with peripheral vascular disease 102
Requirements for angiology/vascular medicine 100
Apolipoproteins and LP(A) correlations in patients at risk 100
Introduction by the Editors 100
Peripheral Arterial Disease : stages I and II 98
Captopril for the Treatment of Patients with Hypertension and Peripheral Vascular Disease 97
Variazioni del quadro lipoproteico in pazienti affetti da cardiopatia coronarica 96
Validity of Out-Patient Screening in Arteriosclerosis to Identify Multiple Lesions 96
Plasma beta-thromboglobulin levels and claudication degrees in patients with peripheral vascular disease 95
Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial 93
Terapia con tiadenolo nei pazienti dislipidemici 93
Flunarazine in the treatment of peripheral vascular disease 92
BTG and PF4 values before and after effort in patients treated with ketanserin 92
Prioritisation of treatments for lower extremity peripheral artery disease in low- and middle-income countries 92
UEMS training requirements for angiology e vascular medicine : European standards of postgraduate medical specialist training (ETR document) 91
Effetto del verapamil SR e del captopril sul metabolismo apolipoproteico in pazienti ipertesi 91
Correlations between fibrinolysis, platelet activation indexes and apolipoprotein profile in patients with dyslipidemias 91
Effectof sympathetic stimuli on platelet activation in patient with essential hypertension or peripheral vascular disease 91
Platelet activation indices and apolipoproteins in hypertensive patients 89
Test da sforzo su ergometro nelle arteriopatie obliteranti periferiche 89
Totale 14.525
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.646
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021963 0 0 0 0 0 0 96 89 161 103 267 247
2021/20221.577 131 55 75 97 83 89 131 160 132 173 82 369
2022/20232.031 295 215 160 244 232 408 54 110 173 33 79 28
2023/2024890 40 93 54 43 190 48 31 60 15 35 105 176
2024/20253.271 138 321 43 330 489 106 62 289 145 300 273 775
2025/20263.093 538 263 520 400 729 487 156 0 0 0 0 0
Totale 17.837